₹ 254.90
-5.10 (-1.96%)Open
261.95High
263Low
253.05Prev Close
260P/E
31.19Median P/E
27.95P/B
2.85Median P/B
4.57Market Cap
12.29BPEG
3.75Div.Yield
1.16Bid
-Ask
-Large Cap
12.29B Mkt. Cap.Volatility
-Beta
0.76Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 262.69 | 262.60 |
10 | 268.26 | 268.25 |
20 | 265.22 | 265.22 |
50 | 260.64 | 260.66 |
100 | 259.86 | 259.86 |
300 | 235.45 | 235.43 |
BSE
524280NSE
KOPRANISIN
INE082A01010Kopran Limited is an India-based integrated pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (APIs). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include anti-infective, amoxycillin, ampicillin, cloxacillin and amoxy clauv. Its non-penicillin-based finished oral dosage forms include macrolides, anti-hypertensive, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management and gastroenterology. It provides ingredients in a wide range of pharmaceutical products, such as capsules, injectables and tablets, among others. The Company's APIs products include anti-hypertensive, macrolides, neuromodulator, urological, anti-infective/anti-acne, sterile carbapenems and sterile cephalosporins.
Surendra Somani
Executive Vice Chairman of the BoardBasant Soni
Chief Financial OfficerSunil Sodhani
Compliance Officer, Company Secretary